Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Essity mulls selling Vinda stake and Consumer Tissue Private Label Europe business

Published 26/04/2023, 14:06
© Reuters. FILE PHOTO: Essity products are seen on display at the venue of a presentation to investors by the hygiene product  company in Stockholm, Sweden May 23, 2019. REUTERS/Anna Ringstrom

STOCKHOLM (Reuters) - Hygiene products group Essity said on Wednesday it has initiated a strategic review of its stake in China-based Vinda and its Consumer Tissue Private Label Europe business.

The Swedish company said in a statement the aim of the review is to reduce its Consumer Tissue division's share of group sales.

"The strategic review includes exploring different options and may result in divestments, although no such decisions have yet been taken," it said.

Essity is the majority shareholder in Hong Kong-based Vinda with a 52% stake.

Vinda in 2022 accounted for 16% of Essity's 156 billion Swedish crowns ($15.16 billion) turnover, while the Consumer Tissue Private Label Europe business represented 6%.

($1 = 10.2929 Swedish crowns)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.